Quarterly Consolidated Statement Of Cash Flows

DAIKEN MEDICAL CO.,LTD - Filing #7303633

Concept 2024-04-01 to
2024-09-30
As at
2024-09-30
As at
2024-03-31
2023-04-01 to
2023-09-30
As at
2023-09-30
As at
2023-03-31
Quarterly consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
709,967,000 JPY
802,293,000 JPY
Interest and dividends received
0 JPY
0 JPY
Interest paid
-4,193,000 JPY
-2,488,000 JPY
Income taxes paid
-232,297,000 JPY
-197,086,000 JPY
Net cash provided by (used in) operating activities
473,476,000 JPY
602,718,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-74,882,000 JPY
-110,958,000 JPY
Net cash provided by (used in) investing activities
-76,035,000 JPY
-110,942,000 JPY
Cash flows from financing activities
Proceeds from long-term borrowings
750,000,000 JPY
JPY
Repayments of long-term borrowings
-219,986,000 JPY
-229,986,000 JPY
Dividends paid
-344,886,000 JPY
-315,557,000 JPY
Net cash provided by (used in) financing activities
20,189,000 JPY
-350,481,000 JPY
Net increase (decrease) in cash and cash equivalents
417,631,000 JPY
141,294,000 JPY
Cash and cash equivalents
3,156,773,000 JPY
2,739,141,000 JPY
2,657,507,000 JPY
2,516,212,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.